Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01635023 · ClinicalTrials.gov registry record · Phase 1
A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT01635023: Completed Phase 1 study, sponsored by AstraZeneca.
NCT01635023 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 27 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01635023, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Study in Healthy Males to Compare the White and Blue Formulations of AZD6244.
Interventions
- DRUG AZD6244 Dosing Period 1
- DRUG AZD6244 Dosing Period 2
- DRUG AZD6244 Dosing Period 3
- DRUG AZD6244 Dosing Period 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-10 |
| Phase | Phase 1 |
What the finished NCT01635023 record still lists
NCT01635023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 4 interventions - of which AZD6244 Dosing Period 1 is the first listed.
NCT01635023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01635023 about?
NCT01635023 is a clinical study titled "A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244". Study in Healthy Males to Compare the White and Blue Formulations of AZD6244.
What is the current status of trial NCT01635023?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2012-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01635023?
The interventions under investigation include: AZD6244 Dosing Period 1 (DRUG), AZD6244 Dosing Period 2 (DRUG), AZD6244 Dosing Period 3 (DRUG), AZD6244 Dosing Period 4 (DRUG).
Who is sponsoring clinical trial NCT01635023?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01635023's enrollment target sits among peer trials
27 1463rd of 2000 higher than 519 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia